Back to Search Start Over

Scalp Tumor and Hydroureteronephrosis in Patients with Nephronophthisis and Homozygous NPHP1 Deletion.

Authors :
Tong H
Zhao F
Yang Y
Qiu X
Zhu L
Yu Z
Source :
Clinical pediatrics [Clin Pediatr (Phila)] 2023 Dec; Vol. 62 (12), pp. 1508-1512. Date of Electronic Publication: 2023 Mar 21.
Publication Year :
2023

Abstract

Homozygous deletion of NPHP1 can lead to isolated nephronophthisis (NPHP) and syndromic disorders. However, the phenotype of scalp tumor and hydroureteronephrosis in NPHP patients with homozygous deletion of NPHP1 has not been reported. Clinical data, laboratory results, and genetic testing of 4 NPHP patients were collected. Examination of their eyes, heart, and urinary tract and of their hepatobiliary, skeletal, and central nervous systems was evaluated. Isolated NPHP was observed in 1 case, and syndromic disorders were observed in the other 3 patients. Their syndromic disorders showed NPHP combined with central nervous system defects, eye involvement, scalp tumor, arachnoid cyst, or hydroureteronephrosis. Large homozygous deletions covering the whole NPHP1 gene locus were identified in all 4 patients. We report a novel phenotype of scalp tumor and hydroureteronephrosis in NPHP patients with homozygous deletion of NPHP1 , paving an avenue for further research on NPHP1 -associated deformity in the skin and the urinary system.<br />Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Details

Language :
English
ISSN :
1938-2707
Volume :
62
Issue :
12
Database :
MEDLINE
Journal :
Clinical pediatrics
Publication Type :
Academic Journal
Accession number :
36942623
Full Text :
https://doi.org/10.1177/00099228231162416